Blood screening for west nile virus: the cost-effectiveness of a real-time, trigger-based strategy.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 16838239.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Previous studies have demonstrated that universal blood screening for West Nile virus is not cost-effective. A newly proposed, real-time, trigger-based screening strategy was analyzed and was also shown to be not cost-effective. These results were highly sensitive to pricing of screening assays.
Medical subject headings
- Mass Screening
- West Nile Fever
- West Nile virus